Document Detail


Does vigorous exercise have a neuroprotective effect in Parkinson disease?
MedLine Citation:
PMID:  21768599     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Parkinson disease (PD) is progressive, with dementia and medication-refractory motor problems common reasons for late-stage nursing-home placement. Increasing evidence suggests that ongoing vigorous exercise/physical fitness may favorably influence this progression. Parkinsonian animal models reveal exercise-related protection from dopaminergic neurotoxins, apparently mediated by brain neurotrophic factors and neuroplasticity (predicted from in vitro studies). Similarly, exercise consistently improves cognition in animals, also linked to enhanced neuroplasticity and increased neurotrophic factor expression. In these animal models, immobilization has the opposite effect. Brain-derived neurotrophic factor (BDNF) may mediate at least some of this exercise benefit. In humans, exercise increases serum BDNF, and this is known to cross the blood-brain barrier. PD risk in humans is significantly reduced by midlife exercise, documented in large prospective studies. No studies have addressed whether exercise influences dementia risk in PD, but exercised patients with PD improve cognitive scores. Among seniors in general, exercise or physical fitness has not only been associated with better cognitive scores, but midlife exercise significantly reduces the later risk of both dementia and mild cognitive impairment. Finally, numerous studies in seniors with and without dementia have reported increased cerebral gray matter volumes associated with physical fitness or exercise. These findings have several implications for PD clinicians. (1) Ongoing vigorous exercise and physical fitness should be highly encouraged. (2) PD physical therapy programs should include structured, graduated fitness instruction and guidance for deconditioned patients with PD. (3) Levodopa and other forms of dopamine replenishment therapy should be utilized to achieve the maximum capability and motivation for patients to maintain fitness.
Authors:
J Eric Ahlskog
Related Documents :
14576519 - Anti-ischemic effects of ivabradine, a selective heart rate-reducing agent, in exercise...
3178619 - Effects of beta-adrenergic blockade on ventilation and gas exchange during incremental ...
11549689 - Tonic sympathetic support of metabolic rate is attenuated with age, sedentary lifestyle...
10516239 - Strenuous resistive breathing induces proinflammatory cytokines and stimulates the hpa ...
7503009 - Role of beta-adrenergic receptor downregulation in the peak exercise response in patien...
2532179 - Beta-endorphin, catecholamines, and cortisol during exhaustive endurance exercise.
23603819 - The experience of breast pain (mastalgia) in female runners of the 2012 london marathon...
18701639 - Lifelong running reduces oxidative stress and degenerative changes in the testes of mice.
2783089 - Severe hypokalemic rhabdomyolysis due to ingestion of liquorice during ramadan.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Neurology     Volume:  77     ISSN:  1526-632X     ISO Abbreviation:  Neurology     Publication Date:  2011 Jul 
Date Detail:
Created Date:  2011-07-19     Completed Date:  2011-09-16     Revised Date:  2013-06-28    
Medline Journal Info:
Nlm Unique ID:  0401060     Medline TA:  Neurology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  288-94     Citation Subset:  AIM; IM    
Affiliation:
Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA. eahlskog@mayo.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Brain-Derived Neurotrophic Factor / metabolism
Disease Models, Animal
Disease Progression
Exercise / physiology*
Humans
Meta-Analysis as Topic
Nerve Degeneration / etiology,  prevention & control*
Parkinson Disease / complications,  rehabilitation*
Physical Fitness / physiology*
Prospective Studies
Chemical
Reg. No./Substance:
0/Brain-Derived Neurotrophic Factor; 0/brain-derived growth factor
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Will cell reprogramming resolve the embryonic stem cell controversy? A narrative review.
Next Document:  Intraepidermal Glandular Carcinoma of the Nipple (Mammary Paget-like Disease) in 2 Dogs.